Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

Indian Journal of Dermatology

Volumn 53, Issue 3, 2008, Pages 140-141

  Mehta, Vandana ^a   Balachandran, C ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Basal cell carcinoma; Imiquimod; Pigmented; Treatment

Indexed keywords

IMIQUIMOD;

ADULT; ANAMNESIS; ARTICLE; BASAL CELL CARCINOMA; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; SKIN BIOPSY; SKIN EXAMINATION; SKIN PIGMENTATION;

EID: 53849141832     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.43204     Document Type: Article

References (6)

1. Jobanputra KS, Rajpal AV, Nagpur NG. Imiquimod. Indian J Dermatol Venereol Leprol 2006;72:466-9.
2. Navi D, Huntley A. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J 2004;10:4.
3. Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double blind, randomized vehicle controlled study. J Am Acad Dermatol 2002;47:390-8.
4. Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6 week dose response trial. J Am Acad Dermatol 2001;44:807-13.
5. Tyring S, Conant M, Marini M, Van Der Meijden W, Washenik K. Imiquimod: An International update on therapeutic uses in dermatology. Int J Dermatol 2002;41:810-6.
6. Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, et al. Imiquimod 5% cream for treatment of superficial and nodular basal cell carcinoma: Randomized studies comparing low frequency dosing with and without occlusion. Br J Dermatol 2002;147:1227-36.